Mandate

Vinge advises Axcel and Acurum Group in connection with the acquisitions of H3o Vatten & Fuktskador and Testab fog & sanering

Vinge has advised Axcel VII and Acurum Group in connection with the acquisitions of H3o Vatten & Fuktskador AB and Testab fog & sanering AB

H3o Vatten & Fuktskador AB and Testab fog & sanering AB are entrepreneur-led, local businesses with expertise in moisture control and moisture and remediation, respectively. Through the acquisition of H3o Vatten & Fuktskador AB, Acurum Group expands its offering in moisture control, with a particular focus on investigation and remediation of water and moisture damage. Testab fog & sanering AB complements the group with a broad offering in asbestos and PCB remediation, as well as other building technology remediation.

Acurum Group consists of companies offering services in air quality, moisture control and pipe maintenance, and has been operating since 2024. The group currently comprises 19 companies in Sweden and Norway, with approximately 600 employees and an annual turnover of approximately SEK 900 million. Each company operates under its own brand but grows through joint initiatives, collaboration and shared expertise within the group.

Vinge's team consisted of Christina Kokko, Elsie Nassar, Robin Sultani, Ida Appelgren and Emma Lundberg (M&A), Amelia Rihs (Employment), Calle Tengwall Pagels (Banking and Finance), Siri Blomberg (Commercial Agreements, IT and GDPR), Madelene Andersson and Stina Larsson (Real Property and Environment) and Julia Ulander Kull

Read the client's press releases here and here.

Related

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025